Skip to content
Ships from Provo, Utah · We ship to CanadaAll Prices are in US DollarsFor Research Use Only. Not for Human Consumption.

How to read an ICP-MS elemental-impurity report

An ICP-MS report can measure selected elements at very low concentrations. The technology is powerful, but the phrase “heavy metals passed” is not an adequate result. A reviewer needs to know which elements were assessed, how the sample was prepared, which interferences were controlled, and how concentration was converted to the stated acceptance limit.

ICP-MS does not measure “all metals” automatically. It measures the elements and isotopes included in a defined analytical procedure.

Where elemental impurities can come from

ICH Q3D describes several potential sources in pharmaceutical contexts:

  • intentionally added catalysts or reagents;
  • raw materials and process water;
  • manufacturing equipment;
  • processing aids;
  • container-closure systems;
  • environmental or handling contamination.

A risk assessment identifies which elements are reasonably expected and which require control. Testing can verify that control strategy, but a short target list should not be described as a comprehensive scan unless that was the method’s validated purpose.

ICP-MS measures ions after sample preparation

The sample is introduced into an inductively coupled plasma, where elements are atomized and ionized. The mass spectrometer measures ions at selected mass-to-charge values.

The instrument does not see the original bulk material directly. Digestion, dilution, transfer, contamination, incomplete recovery, and matrix effects occur before or during measurement. Sample preparation is therefore part of the method, not an administrative detail.

Clear solution does not prove complete digestion

A sample may look clear while some element-containing material remains undissolved, has volatilized, or has adsorbed to a vessel. A credible method justifies acids, temperature, pressure, digestion time, dilution, and final matrix.

Reviewers should look for:

  • sample mass and replicate preparations;
  • reagent grade and vessel cleaning;
  • digestion program;
  • final dilution and acid concentration;
  • filtration or centrifugation, if used;
  • spike recovery or reference-material performance;
  • evidence addressing volatile elements where relevant.

Spectral interference must be evaluated isotope by isotope

An ion at the target mass can originate from another species. Polyatomic ions, doubly charged ions, isobaric overlap, and a high matrix can bias results.

Control strategies can include:

  • selecting a different isotope;
  • collision or reaction cell conditions;
  • mathematical correction;
  • matrix matching;
  • standard addition;
  • separation before measurement;
  • dilution where sensitivity permits.

The report should identify measured isotopes and the interference-control approach. Reporting only element names prevents technical review.

Internal standards monitor, but do not solve, every problem

Internal standards can help correct for changes in sample introduction and instrument response. They should be chosen to behave appropriately across the mass range and matrix.

An acceptable internal-standard response does not prove complete digestion or eliminate a target-specific spectral interference. It is one control within a larger system.

Concentration is not the same as permitted daily exposure

ICH Q3D establishes route-dependent permitted daily exposures for specified elemental impurities in drug products. An analytical result such as micrograms per gram is a concentration. To compare it with a daily-exposure limit, the calculation needs an amount of product used per day and the appropriate route-specific framework.

For example, multiplying a concentration by a maximum daily amount can estimate daily elemental exposure. Without that amount basis, directly comparing ppm with micrograms per day mixes units and can produce a false pass or fail.

For a research material with no approved human use, a pharmaceutical permitted-daily-exposure calculation should not be used to imply that human administration is authorized or safe.

Quality-control results that should accompany samples

  • reagent and method blanks;
  • multi-point calibration standards;
  • independent calibration verification;
  • internal-standard response;
  • interference-check solutions;
  • continuing calibration verification;
  • carryover blank;
  • spike recovery or certified reference material;
  • replicate sample preparations;
  • detection and quantitation limits.

Blank correction is especially important at trace levels. A laboratory should investigate contamination rather than subtracting a large blank without explanation.

Questions to ask about a certificate

  1. Which elements were included, and why?
  2. Were results quantitative or reported only as below a limit?
  3. What were the method detection and quantitation capabilities?
  4. Was the sample fully digested, diluted, or directly analyzed?
  5. Which isotopes and interference controls were used?
  6. Did blank, spike, and calibration checks meet predefined criteria?
  7. Are results linked to the exact lot?
  8. Are units concentration, mass per vial, or estimated daily exposure?
  9. What specification was applied, and is its context appropriate?

A precise conclusion

The validated ICP-MS procedure quantified the listed elements in the identified lot under the stated preparation conditions. Quality controls met the report’s acceptance criteria. The result applies only to the tested elements, lot, units, and specification basis; it does not establish molecular identity, organic purity, sterility, or overall product suitability.

Primary and authoritative sources

  1. FDA/ICH Q3D(R2) Elemental Impurities
  2. USP <233> Elemental Impurities, Procedures
  3. FDA/ICH Q2(R2) Validation of Analytical Procedures
  4. FDA pharmaceutical quality guidance index

Related Serum Research pages

This page explains analytical evidence. It does not certify a laboratory, lot, or material.

Continue reading

Editorial responsibility and corrections

Published by Serum Research. Sources checked October 1, 2026. This is educational material; no independent scientific, clinical, statistical, analytical, or regulatory review is claimed. Read how we review evidence or send a correction.

For Research Use Only. Not for Human Consumption. This page does not provide instructions for medical use or establish the identity, quality, safety, or equivalence of a catalog material.

Information you can check.

Lab reports, store policies, and support — all in one place.

Card options
Visa Mastercard
Available payment options are shown at checkout.
HTTPS connection

For research use only.
Not for human consumption.